- Benzinga Cannabis Daily
- Posts
- 🏖️ Summer Sizzles
🏖️ Summer Sizzles
Market report reveals top-selling weed drinks in U.S.
You're receiving this email because you're subscribed to Cannabis Daily from Benzinga. To manage your subscription, click the link at the bottom of this email.
Happy Thursday Cannabis Investors, and welcome to the cannabis newsletter from Benzinga. The goal of this newsletter is to keep you up-to-date on the fast-moving world of cannabis investing. How? By providing super high-quality content directly to your inbox everyday.
For example, today we’re diving into the sizzling summer trend of THC-infused beverages with a market report that reveals the top-selling weed drinks in the U.S.
In addition to this top story, we’ve also got a daily mix news, analysis, regulatory updates, and much more.
If there are any other ways we can make your life easier, please reply to this email to let us know. Also, if you don’t think this will be a valuable daily resource, you can scroll to the bottom to unsubscribe.
TOP STORY
Briefly: This summer, the THC-infused beverage market is heating up, with a new report revealing the top-selling weed drinks in the U.S. From refreshing seltzers to flavorful tonics, these cannabis-infused beverages are making waves and capturing the attention of both consumers and investors. Curious about which drinks are leading the pack and what makes them so popular?
Click to dive into the latest trends and discover the best-selling THC-infused beverages that are taking the market by storm.
PRESENTED BY CANNABIS CAPITAL CONFERENCE
We have an exciting announcement for our upcoming Benzinga Cannabis Capital Conference on October 8th and 9th in Chicago! The entertainer and founder of Oregon-based Belushi's Farm, Jim Belushi will be joining us as Keynote Speaker.
Don’t miss your chance to be there in person and get your tickets now by following this link, and access a 20% discount using the code JAVI20.
ZINGERS
From Cannabis To Collectibles: Seth Rogen's Passion For Vintage Ashtrays
MariMed Revenue Grows 10.7% QoQ: Hires New CFO And Remains On Track To Deliver 2024 Financial Targets
Curaleaf Posts $48.9M Loss In Q2: What It Means For Your Cannabis Investments
Five Out Of Six Studies On MDMA Show Positive Results: FDA Approval Still Faces Hurdles
Marijuana REIT NewLake Q2 Revenue Up 9.48% YoY: Reports Third Consecutive Quarterly Dividend Increase
ONE MORE FOR THE ROAD
Briefly: In a groundbreaking move for the European cannabis industry, Danish company Stenocare is preparing to launch an innovative medical marijuana oil in Germany. This cutting-edge product promises to revolutionize the treatment of various medical conditions, offering new hope and enhanced therapeutic benefits to patients.Curious about how this could transform medical cannabis in Germany and beyond?
Click to read more about Stenocare's pioneering initiative and its potential impact on the market.
PRESENTED BY CANNABIS CAPITAL CONFERENCE
Join us on October 8th and 9th in Chicago for the world's largest gathering of cannabis investors - happening just ONE month before the Presidential election.
Get your tickets now by following this link, and access a 20% discount using the code JAVI20.
BEFORE YOU GO
Were you forwarded this email? Click here to subscribe.
And be sure to check out our other newsletters:
Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.
Future Finance: Where fintech, crypto, and the future of finance collide. Future Finance is a perfect lunch read packed with quick bites for industry enthusiasts. Subscribe here.
Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.
Mining Weekly: Get an insider's edge with news, analysis, and commentary on what’s shaping the mining and commodities industry that powers the global economy. Subscribe here.